Cantor Fitzgerald’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 430 |
|
|
2025
Q1 | – | Sell |
-5,437
| Closed | -$308K | – | 300 |
|
|
2024
Q4 | $308K | Buy |
+5,437
| New | +$308K | 0.01% | 121 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 238 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 260 |
|
|
2023
Q4 | – | Sell |
-245,520
| Closed | -$14.3M | – | 295 |
|
|
2023
Q3 | $14.3M | Sell |
245,520
-10,364
| -4% | -$602K | 0.38% | 93 |
|
|
2023
Q2 | $16.4M | Sell |
255,884
-2,739
| -1% | -$175K | 0.37% | 97 |
|
|
2023
Q1 | $17.9M | Sell |
258,623
-574
| -0.2% | -$39.8K | 0.38% | 89 |
|
|
2022
Q4 | $18.7M | Buy |
259,197
+4,712
| +2% | +$339K | 0.4% | 76 |
|
|
2022
Q3 | $18.1M | Sell |
254,485
-97,508
| -28% | -$6.93M | 0.4% | 62 |
|
|
2022
Q2 | $27.1M | Buy |
+351,993
| New | +$27.1M | 0.53% | 45 |
|